Pharma Now Partners with the 4th GPCR-Targeted Drug Discovery Summit as Official Media Partner

Mumbai, May 2025 - Pharma Now, the leading business magazine for pharma leaders, is proud to announce itself as the official media partner for the 4th GPCR-Targeted Drug Discovery Summit. The globally recognized summit dedicated to unlocking the next generation of G protein-coupled receptor (GPCR) therapeutics will be conducted from May 20th to 25th in Boston, MA. 

The summit will address the Mechanistic, Pharmacological, and specificity challenges of GPCRs to discover and develop Novel disease-modifying therapeutics for unmet clinical needs.

With more than 800 approved drugs already targeting GPCRs, and many more in the pipeline, this summit comes at a critical juncture where scientific understanding meets clinical advancement. Attendees can expect deep-dive discussions on AI-enabled structure-based design, novel screening technologies, biased signalling, allosteric modulation, and beyond.

Key Highlights of the Summit: 

Novel Modalities Beyond Small Molecules: Unpack the different modalities that can be employed to target different GPCRs and develop more effective & feasible therapeutics, with coverage of antibodies, peptides, ASOs, degraders and more.

Successfully Navigate from Discovery to the Clinic: Overcome challenges in each phase of development to de-risk your programmes and safely translate safe and effective GPCR drugs for a wide range of indications, including diabetes, obesity and CNS disorders.

11+ Brand New Organizations Joining the Speaker Faculty: Gain fresh insights and explore new data through the expert speaker panel, made up of leaders from Discovery, Biology and Chemistry, including brand new companies like Abalone Bio, Biolexis Therapeutics and Structure Therapeutics speaking for the first time.

Ravindra Warang, Editor-in-Chief of Pharma Now, commented on the partnership:

“GPCR-targeted therapies represent one of the most promising frontiers in modern medicine. Partnering with the 4th GPCR-Targeted Drug Discovery Summit allows us to spotlight the brilliant minds and game-changing research that are moving this field forward. At Pharma Now, we’re committed to covering the science that shapes our future.”

The summit will feature sessions from pharma veterans including Jean-Philippe Fortin, Head of Pharmacology (Pfizer), Laetitia Comps-Agrar, Director & Senior Principal Scientist (Genentech), Stephan Schann, CSO (Domain Therapeutics), Wijnand J. C. van der Velden, Senior Scientist (Aikium), Xianqiang Song, Director of Structural Biology (Structure Therapeutics) and Ximena Barros-Alvarez, Senior Scientist - Membrane Protein Biochemistry (Tectonic Therapeutics).

As part of this collaboration, Pharma Now will be offering exclusive coverage before, during, and after the summit—including speaker interviews, expert insights, and event highlights.